Drug Trials Snapshots: VABYSMO (faricimab-svoa)

VABYSMO is a treatment for patients with neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular edema (DME). https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-vabysmo